Glucocorticoid-treated, ARSI-resistant epithelial cells and cancer-associated fibroblasts shared a four-gene glucocorticoid-receptor (GR) core in which monoamine-oxidase-A (MAO-A) was the dominant direct GR target [119]. The gene discussed is NR3C1; the disease is cancer.